| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Epperly Melissa B, is a Chief Financial Officer at ZNTL, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 53 sales. Those positions are worth an estimated $5.7M at current prices.
Our model assigns Epperly Melissa B, a strong insider score of 72/100, based on 13 past trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +39.0%.
Epperly Melissa B,'s largest disclosed position is in ZNTL as Chief Financial Officer, worth about $5.2M. The recent filings there lean toward selling, a net 69,412 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 9,611 | $52.00 | $499,748.14 | +3.7% | +52.2% | -49.7% | |
| Jul 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.27 | $158,054.33 | -1.2% | +19.3% | -43.7% | |
| Jun 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $54.05 | $166,640.95 | -1.2% | +22.1% | -55.8% | |
| May 3, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $59.24 | $182,634.73 | -1.2% | -16.5% | -55.8% | |
| Apr 5, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 17,107 | $43.39 | $742,323.38 | -6.0% | +7.0% | +12.5% | |
| Mar 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $41.67 | $128,482.48 | -1.1% | - | - | |
| Feb 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $37.56 | $115,804.67 | -1.1% | - | - | |
| Jan 4, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.91 | $160,033.81 | -1.1% | - | - | |
| Dec 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 13,684 | $52.18 | $714,059.90 | -4.7% | - | - | |
| Dec 2, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.47 | $158,680.78 | -1.0% | - | - |